Back

Sotatercept is Associated with Improved Lung Function in Sarcoidosis-Associated Pulmonary Hypertension

2025-10-08 respiratory medicine Title + abstract only
View on medRxiv
Show abstract

Sarcoidosis is often complicated by the development of pulmonary hypertension (PH). Sotatercept, a ligand trap for selected transforming growth factor {beta} superfamily members, is a novel, highly effective therapy approved for the treatment of pulmonary arterial hypertension. We conducted a retrospective study of patients with biopsy-proven sarcoidosis who received sotatercept for the treatment of sarcoidosis-associated pulmonary hypertension (PH) to assess the effect of sotatercept on lung fu...

Predicted journal destinations